TITLE

Patients' worries before starting antiretroviral therapy and their association with treatment adherence and outcomes: a prospective study in rural Uganda, 2004 - 2009

AUTHOR(S)
Mayanja, Billy N.; Ekoru, Kenneth; Namugenyi, Harriet; Lubega, Rosemary; Mugisha, Joseph O.
PUB. DATE
June 2013
SOURCE
BMC Research Notes;2013, Vol. 6 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: In HIV-infected persons, good adherence to antiretroviral therapy (ART) is essential for successful treatment outcomes. Patients' worries before starting ART may affect their ART adherence and treatment outcomes. Methods: Between 2004 and 2009, HIV-infected individuals in a prospective cohort study in rural Uganda were assessed for ART eligibility. A counsellor explained the ART eligibility criteria, adherence and side effects, and recorded the patients' worries related to ART. Every quarter, patients who initiated ART had clinical, immunological (CD4 cell counts) and virological (viral loads) assessments, and data were collected on ART adherence using patients' self-reports and pill counts. We describe the patients' worries and examine their association with ART adherence, and immunological and virological outcomes. Results: We assessed 421 patients, 271 (64%) were females, 318 (76%) were aged 30 years and above and 315 (75%) were eligible for ART. 277 (66%) reported any worry, and the proportions were similar by sex, age group and ART eligibility status. The baseline median CD4 counts and viral loads were similar among patients with any worry and those with no worry. The commonest worries were: fear of HIV serostatus disclosure; among 69 (16%) participants, lack of food when appetite improved after starting ART; 50 (12%), concurrent use of other medications; 33 (8%), adherence to ART; 28 (7%) and problems concerning condom use; 27 (6%). After 24 months or more on ART, patients who reported any worry had made more scheduled ART refill visits than patients who reported no worry (p<0.01), but the annual CD4 cell increases were similar (p=0.12). After one year on ART, patients who reported any worry had greater virological suppression than patients who reported no worry (p<0.05). Conclusions: Despite the lack of significant associations of worries with unfavourable ART outcomes, physicians and counsellors should assist patients in overcoming their worries that can cause stress and discomfort. Food supplements may be desirable for some patients initiating ART.
ACCESSION #
88014086

 

Related Articles

  • Early time-limited ART showed better outcomes than deferred therapy.  // Infectious Disease News;Sep2013, Vol. 26 Issue 9, p52 

    The article reports that infants with Human immunodeficiency virus (HIV) treated with early time-limited antiretroviral therapy saw better outcomes compared to those who received deferred treatment, which was concluded by a study on 377 infants younger than 12 weeks with a percentage of CD4+ T...

  • Effect of Nutritional Supplement on the CD4 T-Lymphocyte Counts of Treatment Naïve Asymptomatic HIV Patients in Benin City, Nigeria. OKORIE, E. N.; OPHORI, E. A. // Advances in Bioresearch;Jun2013, Vol. 4 Issue 2, p106 

    The effect of nutritional supplementation with haematinics and multivitamins on CD4+ T-lymphocyte counts of 30 diagnosed anti-retreoviral therapy naïve asymptomatic human immunodeficiency virus (HIV) patients was investigated retrospectively from November 2005 to April 2006. Twenty-five sero-...

  • Abstracts from the current global iterature: Discordant virological and immunological response in antiretroviral therapy. Bharti, Ankit H.; Chotaliya, Kiran; Marfatia, Y. S. // Indian Journal of Sexually Transmitted Diseases;Jan-Jun2013, Vol. 34 Issue 1, p56 

    The article presents abstracts on the discordant virological and immunological response in antiretroviral therapy including its clinical outcome for HIV-infected patients, predictors of immuno-virologic outcomes and immunovirologic discordance and its immunologic failures.

  • Starting Antiretrovirals at Higher CD4 Count Cuts Risk of HIV Transmission.  // HIV Treatment ALERTS!;Apr2012, p3 

    The article presents a study which supports that antiretroviral therapy can limit the spread of HIV by lowering viral load in genital fluids of people with HIV. It mentions that the study provides evidence that starting antiretroviral therapy at a higher CD4 count lowers the risk of AIDS...

  • Impact of Starting CD4 Count, Virologic Failure, and Treatment Interruption on CD4 Gains.  // HIV Treatment ALERTS!;Apr2012, p6 

    The article presents a study which aims to examine how the CD4 count, virologic failure, and treatment interruption before and during antiretroviral treatment affects CD4 gains. It notes that the study found that people who had a virologic failure did not gain as many CD4 cells as people who...

  • Reducing direct causes of maternal death. Pattinson, R. C. // South African Journal of Obstetrics & Gynaecology;Sep2013, Vol. 19 Issue 3, p59 

    The article reports on the launch of a massive campaign to lessen deaths because of complications of HIV infection. It mentions that all pregnant women who are infected with HIV go onto a single-tablet antiretroviral therapy and pregnant women have been introduced on antiretroviral therapy at...

  • Considerations About Risk Factors for Peripheral Neuropathies in Romanian HIV-Infected Patients. GIUBELAN, L. I.; CUPŢA, A.; DUMITRESCU, FLORENTINA; NICULESCU, IRINA; STOIAN, ANDREEA CRISTINA // Fisheries & Aquatic Sciences;Jan2014, Vol. 40 Issue 1, p42 

    Purpose: The study aims at detecting risk factors for developing peripheral neuropathy in Romanian HIV infected subjects. Material/Methods: retrospective study (january 1990-january 2009) who analyzed data from patients hospitalized in the Regional Center Craiova. We have compared 26 patients...

  • Life expectancy of some North Americans with HIV similar to that of general population.  // HIV Treatment ALERTS!;Mar2014, p20 

    The article presents a study which investigates life expectancy in HIV-positive residents of Canada and the U.S. The study included HIV-positive people at least 20 years old who started combination antiretroviral therapy and with CD4 count recorded when they started therapy. The study shows that...

  • Non-AIDS death rate similar with early antiretroviral treatment and in HIV-negative group.  // HIV Treatment ALERTS!;Mar2014, p24 

    The article presents a study which examines the impacts on chances of death with AIDS and non-AIDS on antiretroviral therapy at various CD4 counts. The research team used data from the National Death Index and death certificates to identify whether people died from a non-AIDS disease or AIDS...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics